ASHLEY ADAMS: Open Payments
NPI 1538465570 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$268 in 11 payments from 7 companies in 2025. Trend: 2023 $86 · 2024 $23 · 2025 $268
Food & beverage: $268
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 3 | $73 |
| GENZYME CORPORATION | 2 | $66 |
| Hikma Pharmaceuticals USA | 2 | $43 |
| Astellas Pharma US Inc | 1 | $28 |
| Amgen Inc. | 1 | $26 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 1 | $11 |
Products named: DUPIXENT, Ryaltris, Veozah, TEZSPIRE, NEFFY, VOQUEZNA.
Industry payments across AL — which companies pay providers there.
